Citric acid cycle enzyme substrate (TCA cycle substrate)

Citric acid cycle enzyme substrates are the intermediate metabolites—such as citrate, isocitrate, alpha-ketoglutarate, succinate, fumarate, and malate—that participate in the tricarboxylic acid (TCA) cycle within the mitochondria [1]. These molecules are fundamental to aerobic respiration, serving as the primary source of high-energy electrons for the electron transport chain to generate ATP [1]. While these substrates are not therapeutic targets themselves, the enzymes that catalyze their transformations are critical targets in various diseases [2]. For instance, mutations in enzymes like isocitrate dehydrogenase (IDH) or succinate dehydrogenase (SDH) can lead to the accumulation of specific substrates or their derivatives, known as oncometabolites, which promote cancer progression [2][3]. These oncometabolites, such as 2-hydroxyglutarate, can inhibit other enzymes and alter the epigenetic landscape of the cell [2]. Consequently, drug development focuses on inhibiting these dysfunctional enzymes rather than the substrates themselves [3]. Therapeutic strategies often involve small molecule inhibitors that bind to the mutant enzyme's active site to prevent the production of harmful metabolites [3]. Understanding the flux of these substrates is also vital for diagnosing metabolic disorders and mitochondrial myopathies [1].

Other names

TCA cycle intermediatesKrebs cycle substratesCitric acid cycle intermediates

Not applicable. This entry describes a class of metabolic intermediates rather than a specific therapeutic target protein. Drugs typically target the enzymes that catalyze the conversion of these substrates, such as isocitrate dehydrogenase or succinate dehydrogenase, rather than the substrates themselves [2][3].